← Oncology Approval Tracker

FDA DECISION ·

Jylamvo oral solution

methotrexate · Therakind

FDA approvalNew formulationMycosis fungoides and non-Hodgkin lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Methotrexate oral solution for adults with mycosis fungoides, or as part of a combination regimen in adults with relapsed or refractory NHL.

LAMPGEN ANALYSIS

Why it matters

The original approval includes two adult lymphoma uses for the oral solution.

What research teams should watch

Document the specific lymphoma subtype and verify route, regimen partners and administration schedule.

PRIMARY RECORDS

Sources